People: Aegerion Pharmaceuticals Inc (AEGR.O)

AEGR.O on Nasdaq

25.42USD
24 Apr 2015
Change (% chg)

$-0.52 (-2.00%)
Prev Close
$25.94
Open
$26.05
Day's High
$26.15
Day's Low
$25.40
Volume
297,571
Avg. Vol
548,758
52-wk High
$45.92
52-wk Low
$19.10

Search Stocks

Beer, Marc 

Mr. Marc D. Beer serves as the Chief Executive Officer and Director of Aegerion Pharmaceuticals Inc., since August 2010. From November 2007 to August 2010, Mr. Beer served as a consultant and member of the boards of directors of a number of life sciences companies. From April 2000 to November 2007, Mr. Beer served as the President and Chief Executive Officer of ViaCell, Inc. (a cellular therapy company). Prior to joining ViaCell, he held marketing and business development roles at Genzyme Corporation (a biopharmaceutical company focused on the treatment of rare diseases), most recently serving as Vice President of Global Marketing. Prior to joining Genzyme, he served as Vice President, Sales and Marketing at Biostar, Inc. and held a variety of sales and marketing roles in the pharmaceutical and diagnostic devices divisions of Abbott Laboratories. Mr. Beer holds a B.S. degree from Miami University (Ohio).

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
1,153,800 -- 5,882,740 7,036,540

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 143,380 12,201,500.00
Name Fiscal Year Total

David Scheer

--

Marc Beer

7,036,540

Mark Fitzpatrick

1,888,490

Carolina Alarco

--

Craig Fraser

1,979,770

Anne Cook

2,258,030
As Of  30 Dec 2013
Search Stocks